BACKGROUND: Rest myocardial perfusion imaging (MPI) is effective in managing patients with acute chest pain in developed countries. We aimed to define the role and feasibility of rest MPI in low-to-middle income countries. METHODS AND RESULTS: Low-to-intermediate risk patients (n = 356) presenting with chest pain to ten centers in eight developing countries were injected with a Tc-99m-based tracer, and standard imaging was performed. The primary outcome was a composite of death, non-fatal myocardial infarction (MI), recurrent angina, and coronary revascularization at 30 days. Sixty-nine patients had a positive MPI (19.4%), and 52 patients (14.6%) had a primary outcome event. An abnormal rest-MPI result was the only variable which independently predicted the primary outcome [adjusted odds ratio (OR) 8.19, 95% confidence interval 4.10-16.40, P = .0001]. The association of MPI result and the primary outcome was stronger (adjusted OR 17.35) when only the patients injected during pain were considered. Rest-MPI had a negative predictive value of 92.7% for the primary outcome, improving to 99.3% for the hard event composite of death or MI. CONCLUSIONS: Our study demonstrates that rest-MPI is a reliable test for ruling out MI when applied to patients in developing countries.
BACKGROUND: Rest myocardial perfusion imaging (MPI) is effective in managing patients with acute chest pain in developed countries. We aimed to define the role and feasibility of rest MPI in low-to-middle income countries. METHODS AND RESULTS: Low-to-intermediate risk patients (n = 356) presenting with chest pain to ten centers in eight developing countries were injected with a Tc-99m-based tracer, and standard imaging was performed. The primary outcome was a composite of death, non-fatal myocardial infarction (MI), recurrent angina, and coronary revascularization at 30 days. Sixty-nine patients had a positive MPI (19.4%), and 52 patients (14.6%) had a primary outcome event. An abnormal rest-MPI result was the only variable which independently predicted the primary outcome [adjusted odds ratio (OR) 8.19, 95% confidence interval 4.10-16.40, P = .0001]. The association of MPI result and the primary outcome was stronger (adjusted OR 17.35) when only the patients injected during pain were considered. Rest-MPI had a negative predictive value of 92.7% for the primary outcome, improving to 99.3% for the hard event composite of death or MI. CONCLUSIONS: Our study demonstrates that rest-MPI is a reliable test for ruling out MI when applied to patients in developing countries.
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: J Nucl Cardiol Date: 2002 Mar-Apr Impact factor: 5.952
Authors: Frans J Th Wackers; Kenneth A Brown; Gary V Heller; Michael C Kontos; James L Tatum; James E Udelson; Jack A Ziffer Journal: J Nucl Cardiol Date: 2002 Mar-Apr Impact factor: 5.952
Authors: M E Farkouh; P A Smars; G S Reeder; A R Zinsmeister; R W Evans; T D Meloy; S L Kopecky; M Allen; T G Allison; R J Gibbons; S E Gabriel Journal: N Engl J Med Date: 1998-12-24 Impact factor: 91.245
Authors: G V Heller; S A Stowers; R C Hendel; S D Herman; E Daher; A W Ahlberg; J M Baron; C F Mendes de Leon; J A Rizzo; F J Wackers Journal: J Am Coll Cardiol Date: 1998-04 Impact factor: 24.094
Authors: Jonathan C Knott; Andrew C R Baldey; Leeanne E Grigg; Peter A Cameron; Meir Lichtenstein; Nathan Better Journal: J Nucl Cardiol Date: 2002 May-Jun Impact factor: 5.952
Authors: J L Tatum; R L Jesse; M C Kontos; C S Nicholson; K L Schmidt; C S Roberts; J P Ornato Journal: Ann Emerg Med Date: 1997-01 Impact factor: 5.721
Authors: Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti Journal: Arq Bras Cardiol Date: 2020-02 Impact factor: 2.000
Authors: Gilson Soares Feitosa-Filho; Luciano Moreira Baracioli; Carlos José Dornas G Barbosa; André Franci; Ari Timerman; Leopoldo Soares Piegas; José Antônio Marin-Neto; José Carlos Nicolau Journal: Arq Bras Cardiol Date: 2015-09 Impact factor: 2.000
Authors: Oyebola O Sogbein; Matthieu Pelletier-Galarneau; Thomas H Schindler; Lihui Wei; R Glenn Wells; Terrence D Ruddy Journal: Biomed Res Int Date: 2014-05-11 Impact factor: 3.411